The influence of
slaframine (SF), a parasympathomimetic compound isolated from the fungus Rizoctonia leguminicola, on circulating metabolic
hormone concentrations was investigated in goats. In Exp. 1, SF was administered i.v. at 0 (CONT), 50 (LSF), 100 (MSF), or 150 (HSF) microgram/kg.75 BW in four mature Spanish-cross does (average BW 36 +/- 7 kg) fitted with indwelling jugular vein
catheters in a 4 x 4 Latin square design. Plasma
glucose peaked (P < .06) at 120 min with LSF and at 180 min with HSF and was higher (P <.06) than the CONT at these times.
Glucose exhibited a quadratic response (P < .03) to SF. Area under the response curve for
glucose differed (P < .02) in HSF from CONT and MSF.
Insulin peaked (P < .01) at 240 min with MSF and at 180 min with HSF. Plasma
triiodothyronine was maintained at a higher level (P < .03) with HSF.
Thyroxine peaked (P < .06) at 120 min with MSF and 300 min with HSF. Plasma
NEFA and
somatotropin concentrations were not affected (P > .10) by SF. In Exp. 2, four mature Spanish-cross wethers (average BW 27 +/- 2 kg) fitted with jugular vein
catheters were administered SF (0 and 114 micrograms/kg.75 BW) and
4-diphenylacetoxy-N-methylpiperidine methiodide (4DAMP; 0 and 258 micrograms/kg.75 BW), a M3-muscarinic receptor antagonist, i.v. in a 4 x 4 Latin square design with a 2 x 2 factorial arrangement of treatments. With SF,
glucose peaked (P < .06) at 60 min and
insulin peaked (P < .05) at 180 min. Plasma
triiodothyronine levels were maintained (P < .05) with SF but declined with other treatments. Plasma
NEFA and
thyroxine concentrations remained unchanged regardless of treatment.
Slaframine administration induced
hyperglycemia and
hyperinsulinemia in goats; however, these changes were blocked by preadministration of
isomolar quantities of the M3-muscarinic receptor antagonist, 4DAMP.